• Explore /
  • Poster
  • / The role of tumor vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptors (VEGFR) polymorphisms in the prediction of clinical outcome for advanced hepatocellular carcinoma receiving sorafenib.

The role of tumor vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptors (VEGFR) polymorphisms in the prediction of clinical outcome for advanced hepatocellular carcinoma receiving sorafenib.

Abstract Poster

Authors

null

Luca Faloppi

Scuola di Specializzazione in Oncologia Medica, Un

Luca Faloppi , Mario Scartozzi , Cristian Loretelli , Maristella Bianconi , Riccardo Giampieri , Alessandro Bittoni , Michela Del Prete , Alessandra Mandolesi , Italo Bearzi , Stefano Cascinu

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2013 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Sub Track

Translational Research

Citation

J Clin Oncol 31, 2013 (suppl 4; abstr208)

DOI

10.1200/jco.2013.31.4_suppl.208

Abstract #

208

Poster Bd #

B12

Abstract Disclosures

Similar Posters

First Author: Andrew X. Zhu

First Author: Luca Faloppi

First Author: Philippe Merle

First Author: Julien Edeline